EUVIMEDEUVIMED entdecken
Fallbericht

Outcomes of combination therapy with nusinersen, onasemnogene abeparvovec, and risdiplam over 3.5 years in a patient with prenatally diagnosed spinal muscular atrophy type 0: A case report

Yukimune Okubo, Noriko Togashi, Yuko Morishita, Sayaka Yoshida, Takahiro Kawaji, Aritomo Kawashima, Yu Katata, Saki Uneoka, Yuki Yagi, Wakaba Endo, Takehiko Inui, Tamaki Kato und 4 weitere

Brain and Development · 2026

DOI: 10.1016/j.braindev.2026.104520 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Brain and Development, 2026. Verfasst von Yukimune Okubo und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Neurology, Miyagi Children Hospital, Sendai, Japan. Electronic address: yokubom@yahoo.co.jp. Hauptthemen laut MEDLINE: Spinal Muscular Atrophies of Childhood, Oligonucleotides, Recombinant Fusion Proteins, Pyrimidines. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 20 Literaturangaben. Gefördert von: Japan Agency for Medical Research and Development.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Spinal Muscular Atrophies of ChildhoodOligonucleotidesRecombinant Fusion ProteinsPyrimidinesBiological ProductsHumansFemaleTreatment OutcomeChild, PreschoolDrug Therapy, CombinationMaleGene Therapy AgentsAzo Compounds

Stichwörter der Autor:innen

Case reportNusinersenOnasemnogene abeparvovecRisdiplamSpinal muscular atrophyType 0

Substanzen

nusinersenOligonucleotidesRisdiplamRecombinant Fusion ProteinsPyrimidinesBiological Productsonasemnogene abeparvovecAzo Compounds

Autor:innen und Institutionen

  • Department of Pediatric Neurology, Miyagi Children Hospital, Sendai, Japan. Electronic address: yokubom@yahoo.co.jp.
  • Department of Pediatric Neurology, Miyagi Children Hospital, Sendai, Japan.
  • Department of Rehabilitation and Developmental Support, Miyagi Children's Hospital, Sendai, Japan.
  • Department of Physiological Examination, Miyagi Children's Hospital, Sendai, Japan.
  • Institute of Medical Genetics, Tokyo Women's Medical University, Tokyo, Japan.
  • Department of Pediatric Neurology, Miyagi Children Hospital, Sendai, Japan. Electronic address: khaginoya@kha.biglobe.ne.jp.

Förderung

  • Japan Agency for Medical Research and Development

Zitieren

APA

Okubo, Y., Togashi, N., Morishita, Y., Yoshida, S., Kawaji, T., Kawashima, A., Katata, Y., Uneoka, S., Yagi, Y., Endo, W., Inui, T., Kato, T., Yokomura, M., Otsuki, N., Saito, K., & Haginoya, K. (2026). Outcomes of combination therapy with nusinersen, onasemnogene abeparvovec, and risdiplam over 3.5 years in a patient with prenatally diagnosed spinal muscular atrophy type 0: A case report. Brain and Development. https://doi.org/10.1016/j.braindev.2026.104520

Vancouver

Okubo Y, Togashi N, Morishita Y, Yoshida S, Kawaji T, Kawashima A, et al. Outcomes of combination therapy with nusinersen, onasemnogene abeparvovec, and risdiplam over 3.5 years in a patient with prenatally diagnosed spinal muscular atrophy type 0: A case report. Brain and Development. 2026. doi:10.1016/j.braindev.2026.104520

BibTeX
@article{Okubo2026,
  author = {Okubo, Yukimune and Togashi, Noriko and Morishita, Yuko and Yoshida, Sayaka and Kawaji, Takahiro and Kawashima, Aritomo and Katata, Yu and Uneoka, Saki and Yagi, Yuki and Endo, Wakaba and Inui, Takehiko and Kato, Tamaki and Yokomura, Mamoru and Otsuki, Noriko and Saito, Kayoko and Haginoya, Kazuhiro},
  title = {Outcomes of combination therapy with nusinersen, onasemnogene abeparvovec, and risdiplam over 3.5 years in a patient with prenatally diagnosed spinal muscular atrophy type 0: A case report},
  journal = {Brain and Development},
  year = {2026},
  doi = {10.1016/j.braindev.2026.104520}
}
Kostenlos starten →